Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
CJ de Bode, EJ Dogterom, AVJ Rozeboom… - JIMD …, 2022 - Wiley Online Library
Mucopolysaccharidoses (MPSs) and mucolipidosis II and III (ML II and III) often manifest with
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
[PDF][PDF] Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
CJ de Bode, EJ Dogterom, AVJ Rozeboom… - 2022 - pure.eur.nl
Mucopolysaccharidoses (MPSs) and mucolipidosis II and III (ML II and III) often manifest with
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
CJ de Bode, EJ Dogterom, AVJ Rozeboom… - JIMD …, 2022 - search.proquest.com
Mucopolysaccharidoses (MPSs) and mucolipidosis II and III (ML II and III) often manifest with
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
C de Bode, E Dogterom, A Rozeboom… - JIMD Reports, 2022 - europepmc.org
Mucopolysaccharidoses (MPSs) and mucolipidosis II and III (ML II and III) often manifest with
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
[HTML][HTML] Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
CJ de Bode, EJ Dogterom, AVJ Rozeboom… - JIMD …, 2022 - ncbi.nlm.nih.gov
Mucopolysaccharidoses (MPSs) and mucolipidosis II and III (ML II and III) often manifest with
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
CJ de Bode, EJ Dogterom, AVJ Rozeboom… - JIMD …, 2022 - pubmed.ncbi.nlm.nih.gov
Mucopolysaccharidoses (MPSs) and mucolipidosis II and III (ML II and III) often manifest with
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
[PDF][PDF] Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
CJ de Bode, EJ Dogterom, AVJ Rozeboom… - 2022 - pure.eur.nl
Mucopolysaccharidoses (MPSs) and mucolipidosis II and III (ML II and III) often manifest with
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review.
CJ de Bode, EJ Dogterom, AVJ Rozeboom… - JIMD Reports, 2022 - europepmc.org
Mucopolysaccharidoses (MPSs) and mucolipidosis II and III (ML II and III) often manifest with
orofacial (progressive) abnormalities, which may have a major impact on quality of life …
orofacial (progressive) abnormalities, which may have a major impact on quality of life …